Blood markers to track esophageal cancer treatment response

Researchers are investigating whether changes in specific chemical markers found in blood can help predict how well esophageal cancer treatment is working. The study will follow 300 patients with newly diagnosed esophageal cancer who are receiving different types of treatment—including surgery alone, surgery after chemotherapy, radiation therapy, or chemotherapy combined with immunotherapy. By monitoring these blood markers before and after treatment, doctors hope to find a simpler, faster way to tell whether treatment is working without waiting weeks for imaging scans.

Currently, doctors rely on imaging scans and tumor markers to check whether esophageal cancer treatment is working, but these methods can be slow and may not catch changes early enough. This study exists to see whether blood-based markers could provide faster, more reliable signals of treatment response that might help doctors adjust care plans sooner if a treatment isn't working.